Isabelle Levy-Unger

Vice President International Commercial Operations at BioCryst Pharmaceuticals - Durham, NC, US

Isabelle Levy-Unger's Colleagues at BioCryst Pharmaceuticals
Heather Iocca

Executive Director, Clinical Developmen

Contact Heather Iocca

Carol Richardson

Director, Project Management

Contact Carol Richardson

Tad Gorenflo

Help Desk & Operations Manager

Contact Tad Gorenflo

Eric Bourne

Associate Director, Clinical Development

Contact Eric Bourne

Christine Stanczak

Associate Director Clinical Operations

Contact Christine Stanczak

Alex Sherman

Assoc. Director, Global Market Insights & Analytics

Contact Alex Sherman

View All Isabelle Levy-Unger's Colleagues
Isabelle Levy-Unger's Contact Details
HQ
919-859-1302
Location
Raleigh-Durham, North Carolina Area
Company
BioCryst Pharmaceuticals
Isabelle Levy-Unger's Company Details
BioCryst Pharmaceuticals logo, BioCryst Pharmaceuticals contact details

BioCryst Pharmaceuticals

Durham, NC, US • 250 - 499 Employees
BioTech/Drugs

BioCryst is a North Carolina-based biotechnology company that develops and commercializes novel oral therapeutics for the treatment of various diseases.

Drug Discovery Clinical Development Rare Diseases Regulatory Affairs Product Commercialization B2B Biotech SaaS Commercial Physical Research Biotechnology Biotech Pharmaceuticals
Details about BioCryst Pharmaceuticals
Frequently Asked Questions about Isabelle Levy-Unger
Isabelle Levy-Unger currently works for BioCryst Pharmaceuticals.
Isabelle Levy-Unger's role at BioCryst Pharmaceuticals is Vice President International Commercial Operations.
Isabelle Levy-Unger's email address is ***@bioventusglobal.com. To view Isabelle Levy-Unger's full email address, please signup to ConnectPlex.
Isabelle Levy-Unger works in the BioTech/Drugs industry.
Isabelle Levy-Unger's colleagues at BioCryst Pharmaceuticals are Heather Iocca, Carol Richardson, Laura Stennett, Tad Gorenflo, Eric Bourne, Christine Stanczak, Alex Sherman and others.
Isabelle Levy-Unger's phone number is 919-859-1302
See more information about Isabelle Levy-Unger